Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes fell by 23.1% year on year. With €0.07 Per Capita in 2019, the country was number 4 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes. Iceland ranked the highest with €32 Per Capita in 2019, that is a growth of 3.8% compared to 2018. Iceland recorded the best 5 years average growth at +12.4% per year, while Romania witnessed the worst performance at -39.2% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 0.07 |
| 2018 | 0.06 |
| 2017 | 0.04 |
| 2016 | 0.24 |
| 2015 | 0.03 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes?
| # | 8 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Iceland
|
32.00 | 2019 | +3.8 % | +12.4 % | View data |
| 2 |
#2
Estonia
|
1.76 | 2019 | -7.8 % | NA | View data |
| 3 |
#3
Poland
|
0.27 | 2019 | +50.0 % | +0.8 % | View data |
| 4 |
#4
Portugal
|
0.07 | 2019 | +0.0 % | NA | View data |
| 4 |
#4
Switzerland
|
0.07 | 2019 | +16.7 % | -23.1 % | View data |